As of May 2021 Iperion Life Sciences Consultancy will become a Deloitte business. By combining our specialist industry knowledge and passion for our cause with Deloitte’s network and expertise, we hope to make a greater contribution to the accelerated approval of new or improved medicines as well as the provision of high-quality information to patients […]
Read morePress release: Iperion Life Sciences Consultancy Becomes Part of Deloitte
Published onDeloitte has announced its acquisition of Iperion Life Sciences Consultancy, a dynamic globally-operating firm dedicated to transforming human medicine safety, outcomes and experiences through the application of high-quality, standardized, regulated product information in digital form. As of May 1, Iperion is operating as Iperion – a Deloitte business. The business will run as part of […]
Read moreEuropean Medicines Agency Launches IDMP Implementation Guide and Sets Clock Ticking for Life Sciences Companies to Get Their Data in Order
Published onToday the European Medicines Agency (EMA) has published IDMP data standards that will drive change and innovation in the life sciences sector. Remco Munnik, Associate Director at Life Sciences consultancy, Iperion, has been working with the group creating the EU IDMP Implementation Guide version 2.0 (EU IG). Iperion will reveal the implications of the data […]
Read morePersonal Blog | 2 years at Iperion
Published onA personal story of Julle Vos about his 2-year anniversary at Iperion Life Sciences Consultancy. The 1st of February 2021 marks my second year working for Iperion Life Sciences Consultancy. I must say it was a bit of gamble at first. Having an educational background in biomedical science, it was not entirely what I had […]
Read moreMeet us during DIA’s RSIDM and DIA Europe
Published onWith the start of 2021 we are looking forward to yet another year where we strive to keep making the difference in life sciences. Where we previously shared our vision and knowledge during real life conferences where we could meet face to face and could really connect with the industry, we have to stay flexible […]
Read morePersonal Blog | Setting goals for 2021
Published onA personal story of Sara Brink Berdajs about closing off 2020 and setting goals for 2021 It was around end of October, when I realized that we’re approaching the end of the year. Many of you might recognize the trigger: start of discussions around planning for 2021. Getting the strategic intentions and goals defined, and […]
Read moreReviewing Iperion in the media in 2020
Published onWhile 2020 has proven to be something of a challenge as we battle a virulent pandemic, it has also seen Iperion continue to extend its media presence globally. Here, we look back at some of our favorite topics and link to a handful of key articles. IDMP at a crossroads Frits Stulp reflects on […]
Read moreIperion introduces the IDMP Readiness Questionnaire
Published onIn June, EMA released the draft of the 2nd version of the ‘IDMP/SPOR PMS Implementation Guide’ which is now in the consultation phase. This new release contains an updated chapter 2 (Medicinal Product Information) and a first version of chapter 3 for the process on how product data should be submitted as part of the […]
Read more